Role of Polyunsaturated Fat in Modifying Cardiovascular Risk Associated With Family History of Cardiovascular Disease: Pooled De Novo Results From 15 Observational Studies
Federica Laguzzi,Agneta Åkesson,Matti Marklund,Frank Qian,Bruna Gigante,Traci M Bartz,Julie K Bassett,Anna Birukov,Hannia Campos,Yoichiro Hirakawa,Fumiaki Imamura,Susanne Jäger,Maria Lankinen,Rachel A Murphy,Mackenzie Senn,Toshiko Tanaka,Nathan Tintle,Jyrki K Virtanen,Kazumasa Yamagishi,Matthew Allison,Ingeborg A Brouwer,Ulf De Faire,Gudny Eiriksdottir,Luigi Ferrucci,Nita G Forouhi,Johanna M Geleijnse,Allison M Hodge,Hitomi Kimura,Markku Laakso,Ulf Risérus,Anniek C van Westing,Stefania Bandinelli,Ana Baylin,Graham G Giles,Vilmundur Gudnason,Hiroyasu Iso,Rozenn N Lemaitre,Toshiharu Ninomiya,Wendy S Post,Bruce M Psaty,Jukka T Salonen,Matthias B Schulze,Michael Y Tsai,Matti Uusitupa,Nicholas J Wareham,Seung-Won Oh,Alexis C Wood,William S Harris,David Siscovick,Dariush Mozaffarian,Karin Leander,Fatty Acids and Outcomes Research Consortium (FORCE)
DOI: https://doi.org/10.1161/CIRCULATIONAHA.123.065530
IF: 37.8
2024-01-23
Circulation
Abstract:Background: It is unknown whether dietary intake of polyunsaturated fatty acids (PUFA) modifies the cardiovascular disease (CVD) risk associated with a family history of CVD. We assessed interactions between biomarkers of low PUFA intake and a family history in relation to long-term CVD risk in a large consortium. Methods: Blood and tissue PUFA data from 40 885 CVD-free adults were assessed. PUFA levels ≤25th percentile were considered to reflect low intake of linoleic, alpha-linolenic, and eicosapentaenoic/docosahexaenoic acids (EPA/DHA). Family history was defined as having ≥1 first-degree relative who experienced a CVD event. Relative risks with 95% CI of CVD were estimated using Cox regression and meta-analyzed. Interactions were assessed by analyzing product terms and calculating relative excess risk due to interaction. Results: After multivariable adjustments, a significant interaction between low EPA/DHA and family history was observed (product term pooled RR, 1.09 [95% CI, 1.02-1.16]; P=0.01). The pooled relative risk of CVD associated with the combined exposure to low EPA/DHA, and family history was 1.41 (95% CI, 1.30-1.54), whereas it was 1.25 (95% CI, 1.16-1.33) for family history alone and 1.06 (95% CI, 0.98-1.14) for EPA/DHA alone, compared with those with neither exposure. The relative excess risk due to interaction results indicated no interactions. Conclusions: A significant interaction between biomarkers of low EPA/DHA intake, but not the other PUFA, and a family history was observed. This novel finding might suggest a need to emphasize the benefit of consuming oily fish for individuals with a family history of CVD.